S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.02%) $0.926
USD/NOK
(-0.06%) $10.83
USD/GBP
(-0.11%) $0.791
USD/RUB
(-0.24%) $92.35

Realtime updates for APPILI THERAPEUTICS INC [APLI.TO]

Exchange: TSX Industry: Biotechnology
Last Updated28 Mar 2024 @ 15:13

16.67% $ 0.0350

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 15:13):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada...

Stats
Today's Volume 26 576.00
Average Volume 99 141.00
Market Cap 4.24M
EPS $0 ( 2024-02-11 )
Next earnings date ( $-0.0100 ) 2024-06-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.880
ATR14 $0 (0.00%)

APPILI THERAPEUTICS INC Correlation

10 Most Positive Correlations
ISV.TO0.832
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

APPILI THERAPEUTICS INC Financials

Annual 2022
Revenue: $334 177
Gross Profit: $327 911 (98.12 %)
EPS: $-0.0813
Q3 2023
Revenue: $478 397
Gross Profit: $475 004 (99.29 %)
EPS: $-0.00130
Q2 2023
Revenue: $337 313
Gross Profit: $333 871 (98.98 %)
EPS: $-0.00810
Q1 2023
Revenue: $0
Gross Profit: $-3 442.00 (0.00 %)
EPS: $-0.0128

Financial Reports:

No articles found.

APPILI THERAPEUTICS INC

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. The company has a strategic alliance with AiPharma Global Holdings LLC for the development of Avigan/Reeqonus (favipiravir). Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators